Biotech · Public company · New Haven, CT, US
Trevi Therapeutics, Inc.
Ticker TRVI · SEC CIK 0001563880
Track this companyFree. Adds Trevi Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials102 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline11
- NAL ERPhase 3 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Nalbuphine ER TabletsPhase 3 · Prurigo NodularisClinicalTrials.gov · fetched Nov 12, 2026
- nalbuphine HCl ERPhase 3 · Uremic PruritusClinicalTrials.gov · fetched Nov 12, 2026
- nalbuphine HCl ER tablets 120mg BIDPhase 3 · Uremic PruritusClinicalTrials.gov · fetched Nov 12, 2026
- nalbuphine HCl ER tablets 180 mg BIDPhase 3 · Prurigo NodularisClinicalTrials.gov · fetched Nov 12, 2026
- nalbuphine HCl ER tablets 60 mg BIDPhase 3 · Uremic PruritusClinicalTrials.gov · fetched Nov 12, 2026
- nalbuphine HCl ER tablets 90 mg BIDPhase 3 · Prurigo NodularisClinicalTrials.gov · fetched Nov 12, 2026
- NAL ERPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Nalbuphine ERPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- NintedanibPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- PirfenidonePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) TabletsPHASE3 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07868419 · fetched Nov 12, 2026
- Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) TabletsPHASE3 · RECRUITING · started Jun 29, 2026ClinicalTrials.gov NCT07671911 · fetched Nov 12, 2026
- A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsPHASE1 · COMPLETED · started Feb 27, 2026ClinicalTrials.gov NCT07487740 · fetched Nov 12, 2026
- NAL ER IPF Respiratory Function and Safety StudyPHASE1 · COMPLETED · started Aug 21, 2025ClinicalTrials.gov NCT07036029 · fetched Nov 12, 2026
- A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy ParticipantsPHASE1 · COMPLETED · started Jun 30, 2025ClinicalTrials.gov NCT07015398 · fetched Nov 12, 2026
- Study of Nalbuphine ER in Participants With Hepatic ImpairmentPHASE1 · COMPLETED · started Jun 12, 2019ClinicalTrials.gov NCT04020016 · fetched Nov 12, 2026
- PRISM Study-Pruritus Relief Through Itch Scratch ModulationPHASE2_PHASE3 · COMPLETED · started Aug 7, 2018ClinicalTrials.gov NCT03497975 · fetched Nov 12, 2026
- Study of Nalbuphine HCl ER Tablets in Patients With Prurigo NodularisPHASE2_PHASE3 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02174419 · fetched Nov 12, 2026
- Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic PruritusPHASE2_PHASE3 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02143973 · fetched Nov 12, 2026
- Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic PruritusPHASE2_PHASE3 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02143648 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 17, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 5, 2025 · fetched Nov 12, 2026